Deubiquitinating enzymes as novel anticancer targets

Author： Nicholson Benjamin   Marblestone Jeffrey G   Butt Tauseef R   Mattern Michael R  

Publisher： Future Medicine

ISSN： 1479-6694

Source： Future Oncology, Vol.3, Iss.2, 2007-04, pp. : 191-199

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Intermediate Enzymes of Isoprenoid Metabolism as Anticancer Targets

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 9, Iss. 5, 2009-06 ,pp. : 526-542

Bentham Science Publishers

Access to resources Recommend Favorite

Aurora A and B Kinases - Targets of Novel Anticancer Drugs

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 5, Iss. 3, 2010-11 ,pp. : 219-241

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Anticancer Targets and Drug Discovery in Post Genomic Age

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, Iss. 1, 2005-01 ,pp. : 53-63

Bentham Science Publishers

Access to resources Recommend Favorite

HSP90: a rising star on the horizon of anticancer targets

By Whitesell Luke   Dai Chengkai  

Future Oncology, Vol. 1, Iss. 4, 2005-08 ,pp. : 529-540

Future Medicine

Access to resources Recommend Favorite

Repair and Translesion DNA Polymerases as Anticancer Drug Targets

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 8, Iss. 4, 2008-05 ,pp. : 431-447

Bentham Science Publishers

Access to resources Recommend Favorite